Back to search

Article

Autoantibody origins in lupus and in relapse post CAR-T therapy

2025-10-20

Abstract excerpt

<h4>Summary</h4> Anti-CD19 chimeric antigen receptor (CAR)-T therapy induces profound remissions in lupus by depleting B cells, challenging the longstanding view that treatment-resistant disease is sustained by long-lived plasma cells. Additionally, emerging relapses highlight the need to understand how pathogenic autoantibodies arise. Using molecular antibody tagging in mice with human monogenic lupus variants,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f2fdd8f-f2c5-56fc-b29d-618e1e330018
DOI
10.1101/2025.10.20.683393
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Autoantibody origins in lupus and in relapse post CAR-T therapyDOI 10.1101/2025.10.20.683393
Select a neighboring publication to make it the new centre.